title: [Rhabdomyolysis in severe acute asthma].
abstract: A case is reported of a 74-year-old man who developed rhabdomyolysis during treatment for status asthmaticus. This patient had a history of asthma. He was admitted after a cardiac arrest during a severe asthma attack. Continuous muscle relaxation (4 mg.h-1 of pancuronium for 10 days; total dose 960 mg) was required to carry out mechanical ventilation. Bronchodilators and high doses of steroids (300 mg.day-1 of methylprednisolone for 10 days) were also given. After the administration of muscle relaxant had been discontinued, the patient displayed a severe, predominantly proximal, quadriplegia as well as a raised blood creatinine kinase concentration. The urine was brown coloured over a 24 h period. Rhabdomyolysis was confirmed by muscle biopsy. The patient recovered over a period of one month. This case is discussed in the light of some other similar reports in the literature. It seems that the combination of muscle relaxant with high doses of steroids is to be incriminated.
authors.affiliation: Clinique Neurologique, Hôpital Fontmaure, Chamalières.
authors.forename: P
authors.initials: P
authors.lastname: Clavelou
authors.forename: V
authors.initials: V
authors.lastname: Tubert
authors.forename: O
authors.initials: O
authors.lastname: Mansoor
authors.forename: C
authors.initials: C
authors.lastname: Darcha
authors.forename: D
authors.initials: D
authors.lastname: Guélon
mesh_terms: D000208:Acute Disease; D000368:Aged; D003402:Creatine Kinase / Q000097:blood; D003422:Critical Care; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use; D010197:Pancuronium / Q000009:adverse effects / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000209:etiology*; D013224:Status Asthmaticus / Q000150:complications* / Q000628:therapy
chemical_list: D003402:Creatine Kinase; D010197:Pancuronium; D008775:Methylprednisolone
vernacular_title: Rhabdomyolyse au cours d'un asthme aigu grave.